StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report released on Wednesday. The brokerage issued a sell rating on the stock.
Separately, HC Wainwright raised their price objective on shares of SenesTech from $3.50 to $10.00 and gave the stock a “buy” rating in a research report on Thursday, December 12th.
Read Our Latest Research Report on SNES
SenesTech Price Performance
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Recommended Stories
- Five stocks we like better than SenesTech
- Utilities Stocks Explained – How and Why to Invest in Utilities
- IBM’s AI Bet Pays Off—What’s Next for Investors?
- What is the Euro STOXX 50 Index?
- 3 Reasons to Treat AMD’s Drop as an Entry Opportunity
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Qualcomm’s Post-Earnings Dip: A Prime Buying Opportunity?
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.